Discriminatory Method Development

Discriminatory Method Development is a methodological contribution in pharmaceutical sciences that belongs to the class of analytical method development and is distinguished by its deliberate design to detect and quantify meaningful differences in drug product performance arising from variations in formulation, manufacturing, or storage conditions.

38

Publications

1.6K

Citations

186

Authors

76

Institutions

Publications per year

2017–2026

2

Authors

186

  1. YS
    Yishu Song

    Purdue University West Lafayette, United States

    2 publications · 84 citations

    2

    h-index

  2. EM
    Eva Møller Nielsen

    Statens Serum Institut, Denmark

    2 publications · 161 citations

    2

    h-index

  3. RG
    R. Graham Cooks

    Purdue University West Lafayette, United States

    2 publications · 84 citations

    2

    h-index

  4. YI
    Yasuto Inukai

    Niigata University of Health and Welfare, Japan

    1 publications · 33 citations

    1

    h-index

  5. FF
    Faez Fayad Mohammed Alogaidi

    University of Aberdeen, United Kingdom

    1 publications · 42 citations

    1

    h-index

1–5 of 186

Venues

  1. Journal of Clinical Microbiology

    JCM · 8 publications · 343 citations

    8

    h-index

  2. Journal of Medical Microbiology

    JMM · 3 publications · 86 citations

    3

    h-index

  3. PubMed

    Repository · 2 publications · 69 citations

    2

    h-index

  4. Eurosurveillance

    2 publications · 174 citations

    2

    h-index

  5. Psychometrika

    1 publications · 40 citations

    1

    h-index

1–5